Episode Details
Back to Episodes188 - Chinese Robot Beats Human, AI Beats Doctors, UAE Exits OPEC
Description
Vic and Marcus cover Jerome Powell remaining on the Federal Reserve board and concerns around Fed independence, global instability including the UAE exiting OPEC and weakening international institutions, and hyperscaler dominance with strong earnings from Google, Amazon, and Microsoft driven by AI and cloud growth; they discuss venture funding trends including brain-computer interfaces and clinical AI models, FDA adoption of AI to accelerate clinical trials, and policy shifts including the withdrawal of Casey Means’ nomination and Cigna exiting ACA markets; the episode also explores payer performance, Humana’s partnership with Mark Cuban’s Cost Plus Drugs, pharma consolidation led by Eli Lilly, and rising acquisition costs in biotech; they examine societal impacts of reduced human interaction due to technology, crypto instability and DeFi bailouts, and major AI developments including OpenAI’s slowing growth, legal challenges, China blocking Meta’s acquisition of Manus, and the accelerating gap between AI systems and human expertise in medicine
Links
Story 1: Fed Meeting
3:04 - Powell to Remain on Fed Board, Citing Legal Pressure From Trump WSJ
Story 2: OPEC
5:45 - U.A.E.’s OPEC Exit Deals Major Blow to Cartel Amid Middle East Oil Squeeze WSJ
Story 3: Cloud providers
9:35 - Google Profit Jumps 81% as Cloud Business Booms WSJ
12:49 - Amazon Posts Double-Digit Growth Anchored by Booming Web Services WSJ
13:15 - Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist WSJ
Story 4: VC
15:54 - Axoft Raises $55M Series A to Advance Brain-Computer Interface Technology CityBiz
19:22 - Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model Fierce Healthcare
Story 5: FDA Looking to RWD
24:30 - FDA Turns to AI to Speed Up Clinical Trials WSJ
Story 6: Surgeon General
26:23 - Trump Withdraws Nomination of Casey Means for Surgeon General NYT
Story 7: Payors
29:54 - Cigna to exit ACA market, pursue strategic alternatives for eviCore unit Fierce Healthcare